Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) was a big mover last session, as the company saw its shares rise over 27% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $18.90 –$22.90 in the past one-month time frame, witnessed a sharp increase yesterday.
The move came after news leaked that the company is considering a sale.
The company has seen x negative estimate revisions in the past two months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.
Paratek Pharmaceuticals, Inc. Price and Consensus
Paratek Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
A better-ranked stock in the Biomedical and Genetics industryis Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is PRTK going up? Or down? Predict to see what others think: Up or Down
One Simple Trading Idea
Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.
This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.
Learn more >>
Alexion Pharmaceuticals, Inc. (ALXN): Free Stock Analysis Report
Paratek Pharmaceuticals, Inc. (PRTK): Free Stock Analysis Report
Original post